AVRA Laboratories

Hyderabad, India Founded: 1995 • Age: 31 yrs Acquired By Advent International
Company offering CDMO and custom synthesis services for APIs and Intermediates

About AVRA Laboratories

AVRA Laboratories is a Healthcare company based in Hyderabad (India) founded in 1995, and was acquired by Advent International in January 2022. Company offering CDMO and custom synthesis services for APIs and Intermediates. The company has 371 employees. Its Indian entity Avra Laboratories Private Limited reported revenue of ₹169 Cr. AVRA Laboratories offers products and services including Slot Gaming Platform. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production. Its competitors include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed competitors have raised funding.

Company details

Avra Laboratories was founded in 1995 in Hyderabad, India, as a CRAMS provider in the pharmaceutical sector. Custom synthesis services are delivered, including route identification and optimization for compounds scaled from multi-gram to multi-ton levels. Operations are supported by four manufacturing facilities, one approved by the US FDA. APIs, intermediates, and specialty generics are produced, with capabilities for highly potent APIs at OEL levels from 10 μgm to 1 μgm.

Key Metrics

Products & Services of AVRA Laboratories

AVRA Laboratories offers a comprehensive portfolio of products and services, including Slot Gaming Platform.

Slot Gaming Platform
Online Entertainment

Platform for secure and fair online slot game playing.

Investors in AVRA Laboratories

AVRA Laboratories has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Advent International.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Private equity firm focused on multiple sectors
adventinternational.comSao Paulo, Brazil
Premium access

Investor details for AVRA Laboratories

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Avra Laboratories Private Limited (AVRA Laboratories)

Avra Laboratories Private Limited is the primary company behind AVRA Laboratories. The board of Avra Laboratories Private Limited currently have 3 directors; the longest-serving is Atin Hirachand Jain, appointed in 2022. 10 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Atin Hirachand Jain
DIN 08948630
Director13 Apr 20224 yrs 7 moAvra Laboratories Private Limited
Venkatanaga Kali Vetukuri Vara Prasada Raju
DIN 07267366
Director13 Apr 20224 yrs 7 moAvra Laboratories Private Limited
Jayant Bhalchandra Manmadkar
DIN 03044559
Director13 Apr 20224 yrs 7 moAvra Laboratories Private Limited

People of AVRA Laboratories

6 people are tracked at AVRA Laboratories (2 in leadership, 4 in board & advisors); the tracked headcount is 371.

NameRoleGroup
Ramakrishna Rao
DirectorLeadership
Chandra Ramarao
Joint Managing DirectorLeadership
Martin Smith
Scientific AdvisorBoard & advisors
A. V. Rama Rao
FounderBoard & advisors
Darren Dixon
Scientific AdvisorBoard & advisors
Paul Brennan
Scientific AdvisorBoard & advisors
Premium access

Complete people profiles for AVRA Laboratories

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of AVRA Laboratories

Figures of Avra Laboratories Private Limited, the primary company behind AVRA Laboratories, for FY 2022. Revenue was ₹169 Cr (+45% year on year). Net profit was ₹24.67 Cr (15% margin). EBITDA was ₹39.97 Cr (24% margin). Revenue has grown at a compounded annual rate of +20% over three years and -6% over five years.

  • ₹169 CrRevenue · FY 2022 · +45% YoY
  • ₹24.67 CrNet profit · 15% margin
  • ₹39.97 CrEBITDA · 24% margin
  • ₹7.00 CrPaid-up capital
  • 371Employees (provident fund records)
  • +20%Revenue CAGR, 3 years
  • -6%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Avra Laboratories Private Limited are on its company page.

Premium access

Detailed financial statements for AVRA Laboratories

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of AVRA Laboratories

2 dated milestones of AVRA Laboratories across 27 years, from founding to its latest funding, stage changes and deals.

  1. Founded AVRA Laboratories is founded.
  2. Exit Acquired by Advent International.

Competitors of AVRA Laboratories

AVRA Laboratories has 3 listed competitors in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lauruslabs.com2005Hyderabad, India$229.73M6,035
Pharmaceutical and biotechnology company
symbiotec.in2002Indore, India$61.01M1,822
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
sequent.in2002Bengaluru, India
APIs are developed and manufactured for therapeutic areas.
Premium access

Detailed competitors of AVRA Laboratories

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as AVRA Laboratories (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Avra Laboratories

Premium access

Complete news archive for AVRA Laboratories

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about AVRA Laboratories

AVRA Laboratories was founded in 1995.

AVRA Laboratories is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

AVRA Laboratories has 371 employees.

The primary company behind AVRA Laboratories, Avra Laboratories Private Limited, reported revenue of ₹169 Cr for FY 2022, up 45% year on year.

Avra Laboratories was founded in 1995 in Hyderabad, India, as a CRAMS provider in the pharmaceutical sector. Custom synthesis services are delivered, including route identification and optimization for compounds scaled from multi-gram to multi-ton levels. Operations are supported by four manufacturing facilities, one approved by the US FDA. APIs, intermediates, and specialty generics are produced, with capabilities for highly potent APIs at OEL levels from 10 μgm to 1 μgm.

AVRA Laboratories's top competitors include Laurus Labs, Symbiotec and SeQuent.

AVRA Laboratories offers Slot Gaming Platform.

AVRA Laboratories has 1 investor. Key investors include Advent International.

AVRA Laboratories operates through Avra Laboratories Private Limited.

Yes. AVRA Laboratories was acquired by Advent International in January 2022.

The legal entities of AVRA Laboratories currently have 3 directors, including Atin Hirachand Jain, Venkatanaga Kali Vetukuri Vara Prasada Raju, Jayant Bhalchandra Manmadkar.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available